Supplementary Appendix - Efficacy and Patient-Reported Outcomes from a Phase 2b, Randomized Clinical Trial of Tapinarof Cream for the Treatment of Adolescents and Adults with Atopic Dermatitis

Name: Supplementary Appendix - Efficacy and Patient-Reported Outcomes from a Phase 2b, Randomized Clinical Trial of Tapinarof Cream for the Treatment of Adolescents and Adults with Atopic Dermatitis
Creator: Amy Paller
Published: 2020-08-06T13:42:55.159Z
Keywords: Dermatology, Clinical Trial, Atopic Dermatitis, Topical Treatment

Paller, Amy; Stein Gold, Linda; Soung, Jennifer; Tallman, Anna; Rubenstein, David; Gooderham, Melinda

doi:10.17632/zrmp3sk953.2

Supplementary Appendix - Efficacy and Patient-Reported Outcomes from a Phase 2b, Randomized Clinical Trial of Tapinarof Cream for the Treatment of Adolescents and Adults with Atopic Dermatitis

Published: 6 August 2020| Version 2 | DOI: 10.17632/zrmp3sk953.2

Contributors:

Amy Paller, Linda Stein Gold, Jennifer Soung, Anna Tallman, David Rubenstein, Melinda Gooderham

Description

Mendeley Supplemental Tables and Figures for Paller A, et al. Efficacy and Patient-Reported Outcomes from a Phase 2b, Randomized Clinical Trial of Tapinarof Cream for the Treatment of Adolescents and Adults with Atopic Dermatitis. J Am Acad Dermatol. 2020

Supplementary Appendix - Efficacy and Patient-Reported Outcomes from a Phase 2b, Randomized Clinical Trial of Tapinarof Cream for the Treatment of Adolescents and Adults with Atopic Dermatitis

Description

Files

Categories

Licence